Literature DB >> 1094079

Abnormal renal acidification in alcoholic liver disease.

J R Oster, J L Hotchkiss, M Carbon, C A Vaamonde.   

Abstract

After ingestion of 150 mEq. of calcium chloride (CaCl-2), urinary acidification was studied for 6 hours in 22 normokalemic patients with alcoholic liver disease (L) of varying severity, and in 7 control (C) subjects during 10 studies. The degree of the induced systemic acidosis was similar in all groups. Nine L patients were unable to normally lower urine pH below 5.25 (L-I) and these were compared with the 13 L patients achieving lower pH (L-II) and with control subjects. This defect was consistently reproduced. Titratable acid excretion was less in L-I than in the other groups. The percentage contribution of ammonium to maximal net acid excretion was significantly higher in L-I and L-II than in C. No L-I patient had spontaneous metabolic acidosis, nor was there evidence of encephalopathy or of proximal tubular dysfunction. Sodium excretion was significantly lower in L-I than in either L-II or C. Sodium sulfate and sodium phosphate infused after acid-loading rapidly reduced urine pH into the appropriately acidic range in L-I patients with alcoholic liver disease by means of a simple, safe, and short acid-loading test. Although the mechanism of this renal tubular acidfying defect remains unknown a low distal delivery of sodium by limiting the transtubular potential difference may have been partially responsible.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1094079

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  3 in total

1.  The kidney and liver diseases.

Authors:  S P Wilkinson
Journal:  J Clin Pathol       Date:  1981-11       Impact factor: 3.411

2.  Renal failure in hepatic failure.

Authors:  V P Choudhry; M K Bhan
Journal:  Indian J Pediatr       Date:  1980 Nov-Dec       Impact factor: 1.967

3.  Acquired distal renal tubular acidosis in man.

Authors:  O S Better
Journal:  Klin Wochenschr       Date:  1982-10-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.